Atom | The Accelerating Medicines Partnership (AMP) in Common Metabolic Diseases (CMD) Knowledge Portal: Roadmap for Future Development (Cooperative Agreement, Clinical Trial Optional)

Funder: National Institutes of Health (NIH)

Due Dates: March 1, 2026 (Forecasted)

Funding Amounts: Estimated total program funding: $3,000,000 | Expected number of awards: 1 | Up to 5 years

Summary: Supports the renewal and future development of a knowledge portal aggregating genetic and omic data for type 2 diabetes (T2D) and common metabolic diseases (CMD) to advance disease understanding and therapeutic discovery.

Key Information: This is a forecasted opportunity; dates and details are subject to change.

The Accelerating Medicines Partnership (AMP) in Common Metabolic Diseases (CMD) Knowledge Portal: Roadmap for Future Development (Cooperative Agreement, Clinical Trial Optional)

Sign in to see full grant listing